Insider-Trading
Aktuelle Insider-Transaktionen (SEC Form 4) — Käufe und Verkäufe von Vorständen, Direktoren und Großaktionären.
| Ticker | Insider | Funktion | Datum | Transaktion | Kurs ($) | Stück | Wert ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| MPLT | Catalyst4, Inc. | 10% Owner | 30.07.2026 | Kauf | 13,00 | 1.000.000 | 13.000.000 | Form 4 |
| MPLT | Catalyst4, Inc. | 10% Owner | 29.07.2026 | Kauf | 12,63 | 3.000 | 37.890 | Form 4 |
| MPLT | Catalyst4, Inc. | 10% Owner | 28.07.2026 | Kauf | 11,69 | 65.137 | 761.393 | Form 4 |
| MPLT | Catalyst4, Inc. | 10% Owner | 28.07.2026 | Kauf | 10,74 | 141.088 | 1.515.511 | Form 4 |
| MPLT | Cox Troy | Director | 28.07.2026 | Kauf | 9,52 | 15.620 | 148.702 | Form 4 |
| MPLT | Kreitzer Anatol | Chief Discovery Officer | 17.07.2026 | Verkauf | 38,39 | 200 | 7.678 | Form 4 |
| MPLT | Kreitzer Anatol | Chief Discovery Officer | 17.07.2026 | Verkauf | 37,70 | 14.140 | 533.078 | Form 4 |
| MPLT | Kreitzer Anatol | Chief Discovery Officer | 17.07.2026 | Verkauf | 37,05 | 2.833 | 104.963 | Form 4 |
| MPLT | Gillis Jonathan | CAO and Interim CFO | 17.07.2026 | Verkauf | 38,17 | 900 | 34.353 | Form 4 |
| MPLT | Gillis Jonathan | CAO and Interim CFO | 17.07.2026 | Verkauf | 37,61 | 16.969 | 638.204 | Form 4 |
| MPLT | Gillis Jonathan | CAO and Interim CFO | 17.07.2026 | Verkauf | 36,51 | 600 | 21.906 | Form 4 |
| MPLT | Foff Erin Pennock | Chief Medical Officer | 17.07.2026 | Verkauf | 37,90 | 3.656 | 138.562 | Form 4 |
| MPLT | Hanson Kristopher | General Counsel | 17.07.2026 | Verkauf | 37,90 | 1.130 | 42.827 | Form 4 |
| MPLT | Lillie James Woodruff | Chief Scientific Officer | 17.07.2026 | Verkauf | 37,90 | 2.077 | 78.718 | Form 4 |
| MPLT | Kroeger Christopher A. | Chief Executive Officer | 17.07.2026 | Verkauf | 37,90 | 16.779 | 635.924 | Form 4 |
| MPLT | Kreitzer Anatol | Chief Discovery Officer | 16.07.2026 | Verkauf | 37,44 | 1.592 | 59.604 | Form 4 |
| MPLT | Kreitzer Anatol | Chief Discovery Officer | 16.07.2026 | Verkauf | 36,66 | 7.464 | 273.630 | Form 4 |
| MPLT | Gillis Jonathan | CAO and Interim CFO | 16.07.2026 | Verkauf | 37,44 | 1.476 | 55.261 | Form 4 |
| MPLT | Gillis Jonathan | CAO and Interim CFO | 16.07.2026 | Verkauf | 36,66 | 6.979 | 255.850 | Form 4 |
| MPLT | Foff Erin Pennock | Chief Medical Officer | 16.07.2026 | Verkauf | 37,96 | 19 | 721 | Form 4 |
| MPLT | Foff Erin Pennock | Chief Medical Officer | 16.07.2026 | Verkauf | 37,26 | 5.865 | 218.530 | Form 4 |
| MPLT | Foff Erin Pennock | Chief Medical Officer | 16.07.2026 | Verkauf | 36,46 | 9.163 | 334.083 | Form 4 |
| MPLT | Hanson Kristopher | General Counsel | 16.07.2026 | Verkauf | 37,96 | 11 | 418 | Form 4 |
| MPLT | Hanson Kristopher | General Counsel | 16.07.2026 | Verkauf | 37,26 | 3.331 | 124.113 | Form 4 |
| MPLT | Hanson Kristopher | General Counsel | 16.07.2026 | Verkauf | 36,45 | 4.776 | 174.085 | Form 4 |
| MPLT | Lillie James Woodruff | Chief Scientific Officer | 16.07.2026 | Verkauf | 37,96 | 12 | 456 | Form 4 |
| MPLT | Lillie James Woodruff | Chief Scientific Officer | 16.07.2026 | Verkauf | 37,26 | 3.526 | 131.379 | Form 4 |
| MPLT | Lillie James Woodruff | Chief Scientific Officer | 16.07.2026 | Verkauf | 36,45 | 5.009 | 182.578 | Form 4 |
| MPLT | Kroeger Christopher A. | Chief Executive Officer | 16.07.2026 | Verkauf | 37,96 | 92 | 3.492 | Form 4 |
| MPLT | Kroeger Christopher A. | Chief Executive Officer | 16.07.2026 | Verkauf | 37,26 | 28.091 | 1.046.671 | Form 4 |
| MPLT | Kroeger Christopher A. | Chief Executive Officer | 16.07.2026 | Verkauf | 36,46 | 40.899 | 1.491.178 | Form 4 |
| MPLT | Kreitzer Anatol | Chief Discovery Officer | 15.07.2026 | Verkauf | 36,94 | 4.510 | 166.599 | Form 4 |
| MPLT | Kreitzer Anatol | Chief Discovery Officer | 15.07.2026 | Verkauf | 36,13 | 5.545 | 200.341 | Form 4 |
| MPLT | Gillis Jonathan | CAO and Interim CFO | 15.07.2026 | Verkauf | 36,94 | 4.699 | 173.581 | Form 4 |
| MPLT | Gillis Jonathan | CAO and Interim CFO | 15.07.2026 | Verkauf | 36,13 | 5.356 | 193.512 | Form 4 |
| MPLT | Foff Erin Pennock | Chief Medical Officer | 15.07.2026 | Verkauf | 37,54 | 18 | 676 | Form 4 |
| MPLT | Foff Erin Pennock | Chief Medical Officer | 15.07.2026 | Verkauf | 36,99 | 8.972 | 331.874 | Form 4 |
| MPLT | Foff Erin Pennock | Chief Medical Officer | 15.07.2026 | Verkauf | 36,00 | 4.465 | 160.740 | Form 4 |
| MPLT | Foff Erin Pennock | Chief Medical Officer | 15.07.2026 | Verkauf | 37,04 | 7.845 | 290.579 | Form 4 |
| MPLT | Foff Erin Pennock | Chief Medical Officer | 15.07.2026 | Verkauf | 36,16 | 7.155 | 258.725 | Form 4 |
| MPLT | Hanson Kristopher | General Counsel | 15.07.2026 | Verkauf | 37,54 | 10 | 375 | Form 4 |
| MPLT | Hanson Kristopher | General Counsel | 15.07.2026 | Verkauf | 36,99 | 5.103 | 188.760 | Form 4 |
| MPLT | Hanson Kristopher | General Counsel | 15.07.2026 | Verkauf | 36,00 | 2.147 | 77.292 | Form 4 |
| MPLT | Lillie James Woodruff | Chief Scientific Officer | 15.07.2026 | Verkauf | 37,54 | 12 | 450 | Form 4 |
| MPLT | Lillie James Woodruff | Chief Scientific Officer | 15.07.2026 | Verkauf | 36,99 | 5.393 | 199.487 | Form 4 |
| MPLT | Lillie James Woodruff | Chief Scientific Officer | 15.07.2026 | Verkauf | 36,00 | 2.238 | 80.568 | Form 4 |
| MPLT | Kroeger Christopher A. | Chief Executive Officer | 15.07.2026 | Verkauf | 37,54 | 90 | 3.379 | Form 4 |
| MPLT | Kroeger Christopher A. | Chief Executive Officer | 15.07.2026 | Verkauf | 36,99 | 42.738 | 1.580.879 | Form 4 |
| MPLT | Kroeger Christopher A. | Chief Executive Officer | 15.07.2026 | Verkauf | 36,00 | 18.950 | 682.200 | Form 4 |
Kompakter Markt-Überblick — keine Anlageberatung. Quelle: Fundamentaldaten & SEC-Berichte (Geschäfts- und Quartalsberichte, 10-K/10-Q).